What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His main research concerns Internal medicine, Cardiology, Surgery, Blood pressure and Physical therapy.
In his study, which falls under the umbrella issue of Internal medicine, Rosuvastatin is strongly linked to Placebo.
The study incorporates disciplines such as Confidence interval and Heart rate in addition to Cardiology.
As a member of one scientific family, Christopher M. Reid mostly works in the field of Surgery, focusing on Risk factor and, on occasion, Body mass index, Overweight, Epidemiology and EuroSCORE.
His research in Physical therapy intersects with topics in Ambulatory blood pressure, Randomized controlled trial, Quality of life, Disease and Cohort.
His Myocardial infarction research incorporates themes from Prospective cohort study and Angioplasty.
His most cited work include:
- A Comparison of Outcomes With Angiotensin-Converting--Enzyme Inhibitors and Diuretics for Hypertension in the Elderly (943 citations)
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease (416 citations)
- Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. (396 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Cardiology, Percutaneous coronary intervention, Surgery and Myocardial infarction.
His Internal medicine study focuses mostly on Blood pressure, Heart failure, Cohort, Randomized controlled trial and Hazard ratio.
While the research belongs to areas of Blood pressure, Christopher M. Reid spends his time largely on the problem of Diabetes mellitus, intersecting his research to questions surrounding Incidence.
His studies in Randomized controlled trial integrate themes in fields like Aspirin, Placebo, Clinical trial and Physical therapy.
His work on Ejection fraction, Cardiogenic shock, Atrial fibrillation and Clopidogrel as part of general Cardiology research is frequently linked to In patient, bridging the gap between disciplines.
His Myocardial infarction research is multidisciplinary, incorporating elements of Stroke, Prospective cohort study, Cohort study and Retrospective cohort study.
He most often published in these fields:
- Internal medicine (66.21%)
- Cardiology (33.47%)
- Percutaneous coronary intervention (25.73%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (66.21%)
- Percutaneous coronary intervention (25.73%)
- Myocardial infarction (24.06%)
In recent papers he was focusing on the following fields of study:
Christopher M. Reid spends much of his time researching Internal medicine, Percutaneous coronary intervention, Myocardial infarction, Conventional PCI and Aspirin.
His Internal medicine study incorporates themes from Placebo and Cardiology.
The concepts of his Percutaneous coronary intervention study are interwoven with issues in Incidence, Acute coronary syndrome and Emergency medicine.
The various areas that Christopher M. Reid examines in his Myocardial infarction study include Percutaneous and Cohort study.
His Conventional PCI research is multidisciplinary, relying on both Diabetes mellitus, Renal function and Medical record.
His Aspirin research integrates issues from Interquartile range, Older people, Blood pressure, Post-hoc analysis and Disease.
Between 2019 and 2021, his most popular works were:
- Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. (17 citations)
- Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. (15 citations)
- Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. (15 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His primary scientific interests are in Internal medicine, Heart failure, Placebo, Disease and Aspirin.
His studies deal with areas such as Depression and Cardiology as well as Internal medicine.
His work deals with themes such as Candesartan and Valsartan, which intersect with Cardiology.
He combines subjects such as Patient-centered outcomes, Cohort and Set with his study of Heart failure.
Christopher M. Reid has researched Placebo in several fields, including Clinical trial, Blood pressure and Subgroup analysis.
His Aspirin study integrates concerns from other disciplines, such as Interquartile range, Randomized controlled trial and Placebo-controlled study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
